ClinicalTrials.Veeva

Menu

The RADAR Study - Wearable-Based Dysglycemia Detection and Warning in Diabetes

I

Insel Gruppe AG, University Hospital Bern

Status

Completed

Conditions

Diabetes
Diabetes Mellitus, Insulin-Dependent

Treatments

Other: Wearing smartwatch and continous glucose sensor

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The study RADAR aims at developing a wearable based dysglycemia detection and warning system for patients with diabetes mellitus using artificial intelligence.

Full description

Prior research has investigated the general potential of data analytics and artificial intelligence to infer blood glucose levels from a variety of data sources. In this study patients with insulin-dependent diabetes mellitus will be wearing a continuous glucose meter (CGM) and a smartwatch for a maximum duration of 3 months in an outpatient setting. The gathered data will be used to develop a non-invasive and wearable based dysglycemia detection and warning system using artificial intelligence.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Informed consent as documented by signature
  • Age ≥ 18 years
  • Diabetes mellitus treated with multiple daily insulin injections (MDI) or continuous subcutaneous insulin infusion (CSII)

Exclusion criteria

  • Smartwatch cannot be attached around the wrist of the patient
  • Known allergies to components of the Garmin smartwatch or the Dexcom G6 system
  • Pregnancy, intention to become pregnant or breast feeding
  • Cardiac arrhythmia (e.g. atrial flutter or fibrillation, AV-reentry tachycardia, AV-block > grade 1)
  • Pacemaker or ICD (implantable cardioverter defibrillator)
  • Treatment with antiarrhythmic drugs or beta-blockers
  • Drug or alcohol abuse
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
  • Physical or psychological disease likely to interfere with the normal conduct of the study and interpretation of the study results as judged by the investigator

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems